omniture
LakeShore Biopharma Co., Ltd/湖岸远航生物科技(北京)有限公司

Latest News

LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction

BEIJING, Nov. 4, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "C...

2025-11-04 20:04 1824

LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting

BEIJING, Sept. 22, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biop...

2025-09-22 20:00 2906

LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq

BEIJING, Sept. 12, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biop...

2025-09-12 20:00 1882

LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

BEIJING, Sept. 10, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB,  "LakeShore Biop...

2025-09-10 20:10 1167

LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee

BEIJING, Aug. 28, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Bioph...

2025-08-28 20:00 2313

LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company

BEIJING, Aug. 18, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Bioph...

2025-08-18 20:00 2427

LakeShore Biopharma Announces US$15 Million Private Placement Financing

BEIJING, July 8, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) (the "Company"), a...

2025-07-08 19:25 1697

LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell)

Revolutionizing Vaccination Safety with Needle-Free Reconstitution Technology BEIJING, April 23, 20...

2025-04-23 21:35 2374

LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance

* Achieved total revenue of RMB 371.9 million, reflecting a growth of 36.2% YoY * Achieved gros...

2024-12-19 22:05 4124